StockData
Vertex Pharmaceuticals Inc logo

Vertex Pharmaceuticals Inc

VRTXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 4, 2026Score 15/3036% above fair value
$553.15−5.73 (-1.03%)

Close on Nov 2, 2026Market cap $140.20BP/E 32.2Yield –

Vertex Pharmaceuticals Share repurchases by Year

Share repurchases — Shares repurchased under repurchase programs (M shares) (M)

Vertex Pharmaceuticals Share repurchases: 4.80M in FY2025, up 77.8% from a year earlier.

Latest, FY2025
4.80
Period ended Dec 31, 2025
Change on a year earlier
+77.8%
2.70 in FY2024
History
7 years
Since FY2018
Sources
5
Documents cited below

Where the FY2025 figure comes from

Source: Form 10-K (filed 2026-02-13) ↗

Reported in Form 10-Q / 10-K Note (Common Stock & Share Repurchases).

Annual history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedShare repurchases — Shares repurchased under repurchase programs (M shares) (M)Year on yearSource
FY2025Dec 31, 20254.80+77.8%Form 10-K (filed 2026-02-13) ↗
FY2024Dec 31, 20242.70+107.7%Form 10-K (filed 2026-02-13) ↗
FY2023Dec 31, 20231.30–Form 10-K (filed 2026-02-13) ↗
FY2021Dec 31, 20217.30+204.2%Form 10-K (filed 2024-02-15) ↗
FY2020Dec 31, 20202.40+140.0%Form 10-K (filed 2023-02-10) ↗
FY2019Dec 31, 20191-52.2%Form 10-K (filed 2022-02-09) ↗
FY2018Dec 31, 20182.09–Form 10-K (filed 2021-02-11) ↗

Cite this data

StockData. (2026). Vertex Pharmaceuticals Share repurchases (M), annual FY2018–FY2025 [Data set]. Compiled from Vertex Pharmaceuticals SEC filings and investor materials. https://stockdatahq.com/stocks/vrtx/kpis/buyback-sh-tot

See every metric in the Vertex Pharmaceuticals KPI table. Data updated Nov 2, 2026.